Emmanuelle Girodon

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis harbouring two CFTR Class I variants: real-world data from the French compassionate programme.

Elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis harbouring two CFTR Class I variants: real-world data from the French compassionate programme.

Journal: EClinicalMedicine

Published: July 15, 2025

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Journal: Frontiers in pharmacology

Published: July 07, 2025

Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.

Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.

Journal: The Lancet. Respiratory medicine

Published: March 27, 2025

Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life.

Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: October 22, 2024

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.

Journal: The Lancet. Respiratory medicine

Published: April 11, 2024

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: November 21, 2023

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: November 20, 2023

Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium.

Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium.

Journal: Frontiers in pharmacology

Published: September 13, 2023

Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.

Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.

Journal: The European respiratory journal

Published: September 03, 2023

Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis.

Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 07, 2023

Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.

Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 10, 2023

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.

Journal: The European respiratory journal

Published: January 18, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026